Explore 3 Stock Ideas & Industry Insights Download Free Report

News

This Luxury E-Commerce Group Just Turned Profitable After 15 Months: Full Q4 2026 Breakdown

LuxExperience B.V. (NYSE:LUXE) reported fourth quarter and full fiscal year 2026 results that mark a significant inflection point roughly fifteen months after assuming control of a financially distressed Yoox Net-a-Porter business. The group achieved a positive adjusted EBITDA margin of 0.4 percent for the …

Nitish Kishor | 17 September 2026

Aeluma (NASDAQ:ALMU) Q4 2026 Earnings: Revenue Tops Estimates as AI Datacom Pivot Accelerates

Aeluma, Inc. (NASDAQ:ALMU), a Goleta, California-based semiconductor company developing photonics components for AI data centers, reported fourth quarter fiscal 2026 revenue of 582,000 dollars, narrowly ahead of the 575,000 dollar consensus estimate. Full fiscal year revenue reached 4.5 million dollars, approximately flat compared with …

Nitish Kishor | 17 September 2026

Capri Holdings (NYSE: CPRI) Names Catherine So Chief Legal and Sustainability Officer

So will report to John D. Idol, Capri (NYSE: CPRI)’s chairman and chief executive officer. The company said she will work with its teams to support strategic objectives and continued growth.

Vinay Lochav | 17 September 2026

Neo-Concept (NASDAQ: NCI) Shareholders to Vote on New Articles at AGM

Neo-Concept International Group Holdings Ltd (NASDAQ: NCI) is seekingShareholderapproval for replacement governing documents at its annual general meeting. The proposed rules would remove the requirement for an annual meeting in every fiscal year and leave future meetings to the board’s discretion. They would also …

Vinay Lochav | 17 September 2026

Acumen Pharmaceuticals (NASDAQ: ABOS) Targets Late-2026 Sabirnetug Phase 2 Results

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) expects topline results from its Phase 2 sabirnetug study in late 2026. The company is also targeting a mid-2027 investigational new drug filing for a candidate using Enhanced Brain Delivery technology.

Vinay Lochav | 17 September 2026

Gossamer Bio (NASDAQ: GOSS) Sets October 27 Vote on Warrants and Preferred Stock

Gossamer Bio, Inc. (NASDAQ: GOSS) is asking stockholders to authorize potential common-stock issuances that would exceed 20% of the shares outstanding immediately before the private placement’s initial closing. Approval would cover shares tied to pre-funded warrants, FDA Approval Warrants and the conversion of Series …

Vinay Lochav | 17 September 2026

Sanofi (NASDAQ: SNY) Partnership Keeps 2026 Financial Guidance Unchanged

The arrangement would shift responsibility for thoseAssetsto Cheplapharm while giving Sanofi (NASDAQ: SNY) an ownership interest in its European pharmaceutical partner.

Vinay Lochav | 17 September 2026

CEMTREX INC (NASDAQ: CETX) Acquires PES Assets for $3.5M Cash

The purchase price was $3,500,000 in cash, subject to a working capital adjustment, with certain liabilities also assumed. The transaction took effect on July 1, 2026, and PES operations were integrated into Cemtrex (NASDAQ: CETX)’s Industrial Services Segment. The earnout depends on achieving specified …

Vinay Lochav | 17 September 2026

Aperture AC (NASDAQ: APUR) Sets $150M Atlantic HPC Merger Consideration

Aperture AC (NASDAQ: APUR) agreed to combine with Atlantic HPC Group in a transaction carrying $150,000,000 of SPAC common stock consideration, with each share valued at $10.00. The agreement would make Atlantic HPC Group aWholly Owned Subsidiaryof Aperture AC after the merger. Before closing, …

Vinay Lochav | 17 September 2026

First Hawaiian (NASDAQ: FHB) Puts $2.0B TriCo Deal to October Vote

TriCo shareholders would receive 2.095 First Hawaiian (NASDAQ: FHB) shares for each TriCo share they own.

Vinay Lochav | 17 September 2026
Support

Hi! How can we help you today?

Loading…